Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Freegold Intersects 2.72 g/t Au over 139.9 metres at Golden Summit (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Transcode Therapeutics Inc
RNAZ
Healthcare
Biotechnology
TransCode Therapeutics, Inc. is a clinical-stage oncology company focused on treating metastatic disease. The Company is focused on treating cancer through the design and delivery of ribonucleic acid (RNA) therapeutics based on its TTX nanoparticle platform. The Company’s lead therapeutic candidate, TTX-MC138, is focused on treating metastatic tumors which overexpress microRNA-10b, a unique...
, well-documented biomarker of metastasis. Its preclinical programs include TTX-siPDL1, an siRNA-based modulator of programmed death-ligand 1 (PD-L1), and two indication agnostic programs, TTX-RIGA, an RNA-based agonist of the retinoic acid- inducible gene I (RIG-I), targeting activation of innate immunity in the tumor microenvironment; and TTX- CRISPR, a CRISPR/Cas9-based therapy platform for the repair or elimination of cancer-causing genes inside tumor cells. The Company’s pipeline also includes TTX-mRNA, a tumor-type specific mRNA-based platform for the development of cancer vaccines.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:RNAZ)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
Next
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 25, 2023 12:55pm
RNAZ...Geez, this is Monday isn't it????
It kind of feels like this just might turn into "Fryday" real soon ; )
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 25, 2023 11:35am
RNAZ.....who knows what The Maggots got up his sleeve
Check my last posts.....This MM is a real Dbag I know from personal experience Smoke & mirrors IMHO
Benton Intersects 22.0 m Grading 7.47% Copper Including 8.0 m Grading 11.93%
posted Jan 21, 2025 9:00am by
Benton Resources Inc.
-
|
Grades and widths of this calibre are exceptionally rare in our industry. Confirming gold and copper mineralization in a parallel zone that is associated with an unsourced strong conductor has our team extremely excited ...read more
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 25, 2023 10:59am
RNAZ.... Long halt
start the drumroll
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 25, 2023 10:50am
RNAZ... CRash BOom Bang
told ya tm2324931-7_s1a - block - 6.8539365s (sec.gov)
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 25, 2023 10:29am
RNAZ....Ok Folks.....here is my take .... F.W.I.W ; )
Now I will only say this has the potential to go real high....however....make my word....this is going to end up announcing a P.O Trade accordingly....now Halt #7 and at $3.23 JMHO
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 25, 2023 10:19am
RNAZ..... Bot the dip of course.....now halt #5???
Sold the rip The shorts on RNAZ are all f**Ked ....Yeeha!!
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 25, 2023 9:57am
Well Tarbaby.....You never did answer my post to you on
this board .....or my direct message to you . I guess the writing was on the wall . Good Luck
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 25, 2023 9:38am
RNAZ.....sold to America!!!!
Yeeha & Thank you very much
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 25, 2023 9:25am
RNAZ ....early a.m runner on NR...big volume
TransCode Therapeutics Announces Positive Pre-Clinical Glioblastoma Results with Lead Therapeutic Candidate, TTX-MC138 2023-09-25 05:30 ET - News Release BOSTON, Sept. 25, 2023 (GLOBE
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Sep 25, 2023 8:30am
New Press Release - TransCode Therapeutics Announces Positive Pre-Clinical Glioblastoma Results with Lead Therapeutic Candidate, TTX-MC138
Further Supports TTX-MC138 Application in Brain Cancer BOSTON, Sept. 25, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, announced today positive results with its lead therapeutic...
read article.
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 22, 2023 2:46pm
RNAZ..Trust me..somehow the MM can put up "smoke screens"
like no other...well ...kind of like NBY & REVB All use Level II and the system to their advantage JMHO
(69)
•••
Iseneschal
X
Comment by
Iseneschal
on Sep 22, 2023 2:20pm
RE:RE:RNAZ..This is the sad part about Pre-market & After Hours
Hello Tarbaby...... I am only making assumptions from the date and time of your post....so all I can say is...... You bot the high trade on 09/20/23 Let me know if I am close to being correct ok ? I
...more
(394)
•••
Tarbaby
X
Comment by
Tarbaby
on Sep 21, 2023 1:50am
RE:RNAZ..This is the sad part about Pre-market & After Hours
I see you everywhere I go.. But do you buy or just look.. Whats your best choice.. I bought AVGR and watching it..
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 20, 2023 9:04am
RNAZ..This is the sad part about Pre-market & After Hours
trading. The Powers to be seem to use the system to their own advantage thus eliminating the Retail Traders to capitalize on the share price swings I personally feel that PM & AH Trading should
...more
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 20, 2023 8:39am
RNAZ.....not trying to "pump my book" here but
starting to gain momentum ....now at $0.92 Anything can happen so expect the unexpected Good luck....Cheers !
Prev
1
2
3
4
5
6
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Alphamin Announces Record Fy2024 & Q4 2024 Tin Production Fy2025 Production Guidance Exploration Success
Have you held units of a TD mutual fund, other than through a discount broker? Learn more.
BioVaxys Developing DPX to be the Carrier of Choice for mRNA Vaccines, a market projected to grow to USD$48,000,000,000 by 2030*
Eminent's First Drill Hole Hits Significant Gold-Arsenic in Getchell Trend Analogue and Second Hole Drilling Commences
U.S. DOD Logistics Agency Highlights V.GPH Project to Develop Eco-Friendly Graphite-Based Fire-Fighting Material